Abdelilah El Rhalete, Inas Rhazi, Amine Bensaid, Soufiane Diass, Abderrahim Kaouini, Essaad Ounci, Mohammed Abdi, Mohammed Maarad, Choukri Babouh, Zineb Alami, Naima Abda, Houssam Bkiyer, Brahim Housni
BACKGROUND: COVID-19 is a new disease that appeared in December 2019. Millions of people have been infected and died from this infection. Until today, the pathophysiology and treatment of this infection remain unknown, but a lot of studies are trying to solve the mystery. The trail of inflammation remains the most convincing, especially the Interleukin 6 (IL-6) which could play an important role in a reaction cascade leading to a cytokine storm. According to studies, although few in number, the Tociluzimab (TCZ), which is an anti-IL6, could prevent or even suppress this storm, leading to a less severe clinical state of the disease and a faster recovery...
July 2021: Annals of Medicine and Surgery